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Abstract
Herpesvirus saimiri (HVS), the rhadinovirus prototype, is apathogenic in the persistently infected natural host, the squirrel monkey, but
causes acute T cell leukemia in other New World primate species. In contrast to subgroups A and B, only strains of HVS subgroup C such
as C488 are capable of transforming primary human T cells to stable antigen-independent growth in culture. Here, we report the complete
155-kb genome sequence of the transformation-competent HVS strain C488. The AT-rich unique L-DNA of 113,027 bp encodes at least
77 open reading frames and 5 URNAs. In addition to the viral oncogenes stp and tip, only a few genes including the transactivator orf50
and the glycoprotein orf51 are highly divergent. In a series of new primary HVS isolates, the subgroup-specific divergence of the orf50/orf51
alleles was studied. In these new isolates, the orf50/orf51 alleles of the respective subgroup segregate with the stp and/or tip oncogene
alleles, which are essential for transformation.
© 2003 Elsevier Inc. All rights reserved.
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Introduction
Herpesvirus saimiri (HVS) or saimiriine herpesvirus 2
(SaHV-2) was isolated initially from a kidney cell culture of
a healthy squirrel monkey (Saimiri sciureus) (Melendez et
al., 1968). Although HVS does not cause disease in its
natural host, it induces malignant lymphoma after experi-
mental infection of other New World primate species and
rabbits (Daniel et al., 1974; Melendez et al., 1969; reviewed
in Fickenscher and Fleckenstein, 2001; Fleckenstein and
Desrosiers, 1982). Squirrel monkeys are an endangered spe-
cies of South American rain forests, but are common in zoos
and primate research facilities. Most squirrel monkeys be-
come seropositive during the first year of age and are then
persistently infected by HVS. However, there are no reports
of human tumors associated with squirrel monkeys or HVS.
HVS belongs to the subfamily Gammaherpesvirinae. In
contrast to Epstein-Barr virus (EBV, HHV-4) of the genus
Lymphocryptovirus (1-herpesviruses), HVS was assigned
to the genus Rhadinovirus (2-herpesviruses). The proto-
type rhadinovirus, the HVS strain A11 (Albrecht et al.,
1992a; Falk et al., 1972), is leukemogenic in New World
monkeys such as Aotus trivirgatus, Saguinus oedipus, and
Callithrix jacchus and transforms C. jacchus T cells in vitro
to interleukin (IL)-2-independent growth (Desrosiers et al.,
1986; Szomolanyi et al., 1987). However, strain A11 is
unable to transform human T cells in culture. The saimiri
transformation-associated protein of subgroup A gene
(stpA) is required for T cell transformation in vitro and
leukemogenesis (Desrosiers et al., 1985, 1986; Murthy et
al., 1989). The HVS strain A11 was the first sequenced
rhadinovirus genome (Albrecht et al., 1992a). A genomic
variability between different HVS isolates was detected by
restriction fragment mapping (Desrosiers and Falk, 1982)
and by cross-hybridization with probes from the terminal
coding region (Medveczky et al., 1984).
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The HVS strain C488 from a healthy squirrel monkey of
the New England Primate Research Center (Southborough,
MA) had a restriction enzyme fragment pattern distinct
from strain A11 (Desrosiers and Falk, 1982). After in vitro
infection of primary human blood cells with HVS strain
C488, a reproducible outgrowth of T cell lines was observed
which stably proliferated without restimulation with antigen
or mitogen for more than 18 months of continuous culture
(Biesinger et al., 1992). The HVS-transformed T cell lines
resemble activated mature CD4 or CD8 T cells and
mostly remain dependent on exogenous IL-2. Remarkably,
HVS-transformed human T cells retain the antigen speci-
ficity of their parental clones (reviewed in Fickenscher and
Fleckenstein, 2001).
Besides C488, a few other subgroup C strains such as
C484 and C139 were also reported to transform primary
human T cells, however, apparently less efficiently (Chou et
al., 1995; Fickenscher et al., 1997; Medveczky et al., 1993).
The strain C488 was used most frequently for this applica-
tion (reviewed in Fickenscher and Fleckenstein, 2002).
HVS C488 was pathogenic in S. oedipus and C. jacchus and
transformed T cells from New and Old World primates in
vitro to antigen independent growth (Akari et al., 1996;
Biesinger et al., 1992; Duboise et al., 1998b; Feldmann et
al., 1997; Knappe et al., 1998b, 2000; Meinl et al., 1997).
Although the reinfusion of autologous ex vivo transformed
macaque T cells was well tolerated, HVS C488 induced
lymphoproliferative disease after high-dose viral infection
in the same species (Alexander et al., 1997; Knappe et al.,
2000).
The genes stpC and tip of HVS C488 are both required
for viral transformation and pathogenicity (Duboise et al.,
1998b; Knappe et al., 1997). Both genes are expressed from
a common bicistronic mRNA which is transcriptionally
induced by T cell activation (Fickenscher et al., 1996). stpC
and stpA were oncogenic when expressed in rodent fibro-
blasts or transgenic animals (Jung et al., 1991; Kretschmer
et al., 1996; Murphy et al., 1994). StpC was shown to bind
cellular Ras, to activate mitogen-activated protein kinase,
and to activate the NFB pathway through interaction with
tumor necrosis factor receptor-associated factors (TRAF)
(Jung and Desrosiers, 1995; Lee et al., 1999). StpC mul-
timerization via its collagen-like domain is important for
TRAF association (Choi et al., 2000). StpC mutants with
impaired TRAF binding were nevertheless capable of trans-
forming marmoset lymphocytes, but were deficient for the
transformation of human T cells and rodent fibroblasts in
vitro (Lee et al., 1999). In contrast to StpC, the TRAF
interaction of StpA and StpB does not activate NFB (Choi
et al., 2000; Lee et al., 1999), though StpA is able to
transform rodent fibroblasts (Jung et al., 1991). StpA and
StpB bind to the Src-homology 2 domain of Src which
phosphorylates StpB in vitro and in vivo (Choi et al., 2000;
Ho¨r et al., 2001).
The first open reading frame (ORF) in the unique L-
DNA of HVS C488 and other subgroup C strains encodes a
protein that binds to the tyrosine kinase Lck in transformed
T cells, termed tyrosine kinase-interacting protein or Tip
(Biesinger et al., 1990, 1995; Fickenscher et al., 1997; Lund
et al., 1995, 1996). Although tip does not exert transforming
activity in fibroblasts, it induces T cell lymphoma in con-
ditionally transgenic mice (Wehner et al., 2001). Thus, tip
and stpC are the oncogenes of HVS subgroup C strains. Tip
associates with Lck via the proline-rich Src-homology re-
gion 3 binding (SH3B) and the C-terminal Src-kinase ho-
mology domain (CSKH) (Jung et al., 1995a). In many test
systems, the Tip-interaction resulted in enzymatic Lck ac-
tivation (Fickenscher et al., 1997; Hartley et al., 1999; Lund
et al., 1997a; Noraz et al., 1998; Wiese et al., 1996). Both
the SH3B and the CSKH domains of Tip were required for
Lck activation (Hartley et al., 2000). However, when stably
expressed in transfected cell lines, Tip caused a marked
inhibition of Lck-mediated signal transduction (Jung et al.,
1995b). Surprisingly, the mutation of the Tip SH3B domain
did not block marmoset T cell transformation (Duboise et
al., 1998c). Moreover, the Tip mutant Y114S further en-
hanced Lck downregulation and reversed the transformed
phenotype of cells with a constitutively active Lck mutant
(Guo et al., 1997). The phosphorylation of exactly this
tyrosine residue in Tip is required for the binding of signal
transducer and activator of transcription (STAT) factors
(Hartley and Cooper, 2000). Tip induces an Lck-dependent
activation of STAT1 and STAT3 and promotes STAT-
dependent transcription (Lund et al., 1997b, 1999).
Since the transforming stp and tip genes are necessary
for transformation and pathogenicity (Duboise et al., 1998b;
Knappe et al., 1997), they are the major determinants for the
transforming potential of the different HVS strains. How-
ever, as experiments with retroviral stp and tip expression
constructs in absence of the herpesvirus genome have not
been successful, it is not clear if stp and tip are sufficient for
transformation. Therefore, we have now established the
entire nucleotide sequence of HVS C488 to learn which
additional viral factors are variable and, thus, might con-
tribute to the different phenotypes of the HVS subgroups.
Results and discussion
The genome of HVS C488
The genome length of the packaged linear virion DNA
was determined with density gradient-purified DNA by
pulse-field electrophoresis. The maximal signal intensity
corresponded to an entire genome size of approximately 155
kb, ranging from 130 to 165 kb (Fig. 1). Digestion with the
restriction endonuclease EagI yielded a linear fragment of
approximately 113 kb covering the coding unique L-DNA,
and in addition, two supermolar fragments of 1.3 and 1.45
kb corresponding to the terminal repetitive H-DNA (data
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not shown). Thus, the H-DNA comprises 40 kb (17 to 52
kb) or on average 25% of the packaged DNA genome.
Various strategies were combined for sequencing of the
entire herpesvirus genome: Either cloned XbaI or HindIII
restriction fragments, or cloned random fragments from
sonicated DNA, or PCR fragments were sequenced. Larger
fragments in plasmids or cosmids were covered by primer
walking. Totally, 1757 independent sequence readings
yielded 898,756 bp of uncompiled raw data that were as-
sembled into a contiguous sequence of 113,027 bp AT-
rich unique L-DNA and the terminal repetitive GC-rich
H-DNA of 1458 bp. The average redundance was 8.1, and
all regions were covered by at least two readings on each of
both strands. The terminal GC-rich H-DNA repeats of
strain C488 are composed of two units of different sizes.
The EagI restriction enzyme recognition site defines two
distinct repeat units of 1318 and 1458 bp. The shorter unit
represents the longer repeat unit of which 140 bp are de-
leted. The deleted area includes the putative cleavage sig-
nals of the virus packaging enzymes (Bankier et al., 1985;
Stamminger et al., 1987). The H- to L-DNA transition
region contains a stretch of rearranged GC-rich DNA
which cannot be perfectly aligned to the H-DNA repeat
sequences (Albrecht et al., 1992a). For the C488 L-DNA
sequence, we defined the H-/L-DNA transition site and the
left genomic terminus of the L-DNA as the first predicted
packaging cleavage site of the H-DNA. Accordingly, the
L-DNA between positions 1 to 622 is GC-rich and con-
sists of rearranged H-DNA sequences. The right terminal
end of the C488 L-DNA is precisely defined by the begin-
ning of an H-DNA repeat unit. Based on this definition, the
unique L-DNA region had an average GC content of
34.5% and a CpG dinucleotide frequency suppression rate
of 0.32 (identical to A11) (Albrecht et al., 1992a). The
1458-bp repetitive terminal H-DNA had 69.9% GC con-
tent (70.8% in A11).
Repetitive regions in the HVS A11 L-DNA occur in
orf48 and orf73, between orf15 and orf16, and between
orf70 and orf71 (Albrecht et al., 1992a). The location of all
these repetitive sequences is conserved in HVS C488.
ORF48 carries a large C-terminal domain consisting of
repeated Gln and Asp residues which is clearly divergent
between A11 and C488 (63.8% nucleotide conservation of
ORF48; different arrays of Gln and Asp residues). In the
genomes of Kaposi’s sarcoma-associated herpesvirus
(KSHV), Rhesus monkey rhadinovirus (RRV), alcelaphine
herpesvirus type 1 (AHV-1), bovine herpesvirus type 4
(BHV-4), and murine gamma-herpesvirus 68 (MHV-68), a
GC-rich region is present between orf70 and orf71. In
BHV-4, this region is composed of a highly AT-rich
sequence of 750 bp, followed by two GC-rich stretches of
multiple direct repeats R2a and R2b; R2b is the major
element of the replication origin identified within this region
in BHV-4 (Zimmermann et al., 2001). However, in HVS
and the closely related herpesvirus ateles (HVA) this region
is devoid of these GC-rich repetitive elements, but con-
tains palindromic and AT-rich sequences only (Albrecht,
2000; Lang and Fleckenstein, 1990). In HVS A11, the
origin of lytic replication was mapped to this region
(Schofield, 1994).
Coding capacity of the HVS C488 genome
Upon analysis of the C488 genome, ORFs were defined
as previously done for other herpesviruses (Albrecht, 2000;
Albrecht et al., 1992a; Ensser et al., 1997; Nicholas, 1996):
(a) ORF size following an ATG codon larger than 60 aa; (b)
presence of potential transcriptional start sites and polyad-
enylation sites; (c) high GENEMARK score (0.5); (d)
homology to previously described herpesviral or cellular
genes. The longest of several overlapping ORFs was con-
sidered significant. By employing these criteria, we deter-
mined 77 potential ORFs as shown in Table 1 and Fig. 2A.
Shorter ORFs, ORFs without ATG start codons, or ORFs
derived from spliced messages would however be missed by
this approach. The ORF nomenclature followed the rhadi-
noviral prototype sequence of the HVS strain A11 (Albrecht
et al., 1992a).
Fig. 1. HVS genome size. Clamped homogenous electric field electrophoresis was performed with purified virion DNA of HVS strain C488 (lanes 2 and 3).
Marker (lane 1): mid-range DNA marker (New England Biolabs). Top, a densitometric evaluation of the gel is shown.
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Table 1
HVS ORFs and related ORFs in the rhadinoviruses HVA, KSHV, and RRV
ORF Stranda Start/exon1 Stop/exon2 n
(aa)
kDa
predicted
Signal
peptideb
aa id (%)c
HVS A11
aa id (%)
HVA
aa id (%) RRV aa id (%)
KSHV
Description, homology
withd
c 1465 695 266 28.7 nh 32.8 to Tio nh nh Tyrosine-kinase interacting
protein, Tip
1 c 2091 1783 102 9.9 23.2 to StpA 40.0 to Tio 40.0 to ORF73
(GPP)
nh Saimiri transformation-
associated protein, StpC
2 c 5344 4703 213 24.6 80.5 nh 57.2 43.1 vDHFR
3 d 6602 10342 1246 138.5 93.6 70.1 nh; 25.4 to
ORF75
nh; 26.9 to
ORF75
vFGARAT
4a d 10636 11718 360 40.6 20 61.4 60.3 34.2 34.1 Complement control protein
homolog, membrane form
4b d 10636/11497SD SA11691/11740 303 33.8 20 57.3 57.6 ns ns Complement control protein
homolog, soluble form
5 c 11952 11720 78 9.1 51.3 nh nh nh
6 d 12310 15696 1128 127.6 97.5 86.5 54.3 55.0 Major single-stranded DNA
binding protein, mDNA-BP
7 d 15703 17742 679 77.6 96.6 83.5 47.7 44.8 Processing and transport
protein
8 d 17732 20158 808 91.8 19 96.5 86.0 55.4 56.0 Glycoprotein B
9 d 20232 23261 1010 114.2 97.8 87.7 62.6 62.3 DNA polymerase
10 d 23298 24521 407 45.2 98.8 82.6 25.6 25.4 Raji LF1 EBV
11 d 24524 25741 405 45.8 98.3 76.3 32.4 31.1 Raji LF2 EBV
12 c 26279 25770 169 19.4 90.5 nh nh 26.6 to K3;
22.6 to K5
13 c 27122 26667 151 17.2 22 98.0 nh nh nh vIL-17
14 c 28140 27394 248 28.2 33 94.8 49.6 nh nh vSag
15 d 28946 29296 116 13.2 19 91.4 nh nh nh vCD59
16 d 30036 30518 160 18.0 92.5 65.6 23.9 22.5 vBcl2
17 c 31972 30548 474 53.0 96.0 74.0 47.0 44.3 Protease/capsid protein,
minor capsid scaffold
protein
18 d 31965 32735 256 29.9 97.3 80.5 49.6 48.8
19 c 34363 32732 543 61.3 97.8 79.6 47.9 45.4 Virion tegument protein
20 c 34904 33903 333 34.9 96.0 68.0 39.1 43.8 Fusion protein
21 d 34903 36486 527 60.0 96.0 75.2 34.8 31.7 Thymidine kinase
22 d 36483 38636 717 82.7 16 88.4 83.8 32.9 35.7 Glycoprotein H
23 c 39390 38629 253 28.9 99.2 82.0 31.7 36.9
24 c 41589 39400 729 83.3 98.1 81.5 46.8 46.9
25 d 41601 45716 1371 154.2 99.3 89.4 67.5 65.9 Major capsid protein
26 d 45732 46646 304 34.4 100.0 90.1 58.2 57.9 Capsid protein VP23
27 d 46653 47495 280 32.4 99.3 69.6 30.8 33.0
28 d 47570 47785 71 7.6 35 82.4 73.2 22.4 32.4
29 c 52932/52024SD 48940SA/47795 684 76.9 97.7 87.0 59.5 59.6 DNA packaging protein,
terminase
30 d 48958 49185 75 8.3 94.7 82.7 33.3 33.3
31 d 49152 49772 206 24.3 99.0 90.2 42.5 44.8
32 d 49724 51049 441 50.9 97.1 71.7 34.5 33.2
33 d 51042 52034 330 37.0 98.5 80.3 39.1 37.5
34 d 52931 53881 316 36.2 98.1 87.0 43.3 43.5
35 d 53868 54320 150 17.3 98.0 77.6 40.4 32.9
36 d 54208 55503 431 48.8 98.8 81.6 29.4 32.2 Phosphotransferase,
possible tyrosine kinase
37 d 55503 56954 483 55.6 99.0 87.8 53.0 50.5 Alkaline exonuclease
38 d 56909 57109 66 7.6 95.5 71.2 33.3 41.4 N-myristoylated in HSV
39 d 57134 58234 366 42.2 37 98.4 84.7 57.8 51.8 Glycoprotein M, integral
membrane protein
40 d 58319 59671 450 51.9 95.6 69.2 30.5 28.1 Helicase–primase complex
41 d 59804 60289 161 18.7 96.3 75.0 33.1 31.1 Helicase–primase complex
40/41 d 58319/59638SD SA59723/60289 628 72.6 95.9 70.2 — — Spliced in EBV
(BBLF23)
42 c 61078 60281 265 30.0 98.5 80.8 41.2 41.2
43 c 62735 61044 563 64.0 99.6 89.2 57.3 60.7 Minor capsid protein, virion
protein
44 d 62710 65055 781 88.2 99.5 89.8 62.8 61.5 Helicase–primase complex,
helicase
45 c 65869 65093 258 28.3 95.0 61.8 35.7 31.9
46 c 66638 65880 252 28.9 95.2 85.3 58.7 59.4 Uracil DNA glycosylase
47 c 67032 66616 138 15.7 23 69.3 73.2 29.6 29.8 Glycoprotein L (CMV),
N-myristoylation signals
48 c 69191 67038 717 83.9 63.8 51.9 31.9 28.8 Glu and Asp-rich, repetitive
structure
49 c 70312 69401 303 35.8 94.7 73.7 25.6 22.3
50a d 69354/69374SD SA70334/71875 520 58.3 70.6 ns ns ns Rta homolog, exons 12
50b d 70829 71875 348 38.5 70.4 71.2 28.9 27.0 Rta homolog, exon 2
51 d 72371 73264 297 33.2 17 39.0 38.2 ph ph Putative virus specific
glycoprotein
52 c 73644 73297 115 13.1 62.3 66.0 33.9 32.2
53 c 73958 73686 90 10.4 19 63.3 60.7 35.6 35.6 Putative glycoprotein N
54 d 74035 74898 287 32.3 94.1 74.2 39.4 33.9 Deoxyuridine
triphosphatase, dUTPase
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Within the L-DNA, HVS C488 encodes at least 77 ORFs
and 5 URNA genes. The conserved herpesviral ORFs are
arranged in four gene blocks that separate the five regions
containing genes which are conserved among the rhadino-
viruses and not found in other herpesviruses. At least 10
viral genes share homology with cellular genes, and most of
these C488 genes were found to be highly conserved in
A11. The only gene absent in the prototype strain A11 was
the transformation-associated tip gene, next to the position-
ally conserved transforming stp. Thus, the major difference
between HVS C488 and A11 are the two genes stpC and tip
instead of stpA and the fact that HVS C488 carries only five
(HSUR 1, 2, 5, 4, and 7) instead of seven URNA transcrip-
tion units of strain A11 (Albrecht et al., 1992a; Biesinger et
al., 1990).
In contrast to stpC and tip, which are essential for trans-
formation and pathogenicity (Duboise et al., 1998b; Knappe
et al., 1997), the C488 URNAs were dispensable for the in
vitro transformation of simian and human T cells (Ensser et
al., 1999). The EBERs of EBV are also dispensable for B
cell transformation (Swaminathan et al., 1991), although
recent work suggested that they may promote tumorgenicity
of EBV-negative Burkitt lymphoma cells (Komano et al.,
1999; Ruf et al., 2000). In this genomic region, the diver-
gence between different HVS strains appears to be in the
same order of magnitude as between HVS and HVA. In-
stead of StpC and Tip, HVA encodes the protein Tio (two-
in-one) expressed from a spliced transcript. Tio combines
N-terminal motifs reminiscent of the StpC collagen repeats
with the SH3B and CSKH regions of Tip. Similarly to the
HVS oncoproteins StpA, StpB, and Tip, Tio binds to and is
phosphorylated by Src-family tyrosine kinases Lck, Src, and
Fyn. HVA carries only two URNA genes which seem to be
homologs to HSUR1 and HSUR2, while a dehydrofolate
reductase (DHFR) gene is missing (Albrecht, 2000; Al-
brecht et al., 1999).
Besides the transformation-associated region, most other
ORFs were highly conserved between C488 and A11 with
amino acid identities exceeding 90%. However, the pre-
dicted protein sequences of ORF4 (complement control
protein homolog, CCPH; 61.4% aa identity), ORF5
(51.3%), ORF22 (gH; 88.4%), ORF28 (82.4%), ORF47
(gL; 69.3%), ORF48 (repetitive sequence; 63.8%), ORF50
(R-transactivator, Rta; 70.6%), ORF51 (glycoprotein;
39.0%), ORF52 (62.3%), ORF53 (putative gN; 63.3%),
ORF65 (capsid protein; 70.5%), and ORF73 (homolog to
Table 1 (continued)
ORF Stranda Start/exon1 Stop/exon2 n
(aa)
kDa
predicted
Signal
peptideb
aa id (%)c
HVS A11
aa id (%)
HVA
aa id (%) RRV aa id (%)
KSHV
Description, homology
withd
55 c 75533 74931 200 22.3 99.5 84.0 48.7 47.5
56 d 75512 78019 835 95.9 98.1 80.7 43.9 45.4 Helicase–primase complex,
DNA-replication, primase
57 d 78086/78134SD SA78224/79461 427 48.0 98.6 ns ns 26.3 IE52, spliced form
57b d 78301 79458 385 43.4 98.7 75.1 34.7 29.2 Exon2 of IE52
58 c 80879 79806 357 40.6 98.3 83.0 30.6 28.5
59 c 81991 80876 371 40.7 95.1 74.9 37.7 36.1 Processivity factor, subunit
of DNA-polymerase
60 c 83019 82102 305 35.1 98.7 91.8 62.5 64.9 Ribonucleotide reductase,
small subunit
61 c 85328 83025 767 87.3 97.4 89.8 54.0 53.4 Ribonucleotide reductase,
large subunit
62 c 86320 85328 330 37.4 99.1 85.2 42.8 39.8 Probable capsid assembly
and DNA maturation
protein
63 d 86327 89023 898 103.3 97.8 75.9 35.4 32.0 Legument protein
64 d 89026 96459 2477 281.2 94.4 72.0 32.3 31.7 Large tegument protein
65 c 96879 96463 138 15.2 70.5 61.9 39.9 35.5 Capsid protein
66 c 98179 96872 435 50.3 97.9 80.8 35.4 37.4
67 c 98799 98092 235 26.9 97.4 84.4 51.8 53.8 Tegument protein
67.5 c 99041 98796 81 9.2 98.8 85.0 50.0 41.6 After frame shift correction
in strain A11 (G inserted
after pos. 99117)
68 d 99046 100356 436 49.1 97.7 78.0 49.3 45.6 Probable major envelope
glycoprotein
69 d 100359 101144 261 29.8 99.2 88.8 51.0 54.2
70 c 102267 101383 294 33.5 98.0 85.5 65.6 66.0 Thymidylate synthase
71 c 104988 104485 167 19.2 94.0 44.8 14.5 20.0 vFLIP, FLICE interacting
protein, inhibitor of
apoptosis
72 c 105753 104989 254 28.6 98.4 74.0 31.3 34.8 vCyclin
73 c 107314 105809 501 55.6 76.1 44.2 21.3 30.7 LANA homolog, repetitive
structure
74 d 107813 108877 354 37.1 96.0 70.1 33.6 35.9 vGPCR, IL-8 receptor
75 c 112761 108862 1299 143.3 95.7 73.9 35.5 36.9 Virion protein, vFGARAT
a d, ORF encoded on direct strand; c, complementary strand
b Signal peptide length predicted by SignalP
c Amino acid identity calculated with the GCG program GAP (standard parameters, gap creation penalty 8, gap extension penalty 2).
d For comparison see Albrecht (2000); Albrecht et al. (1992a); Alexander et al. (2000); Russo et al. (1996); Searles et al. (1999). ns, no splicing data
available; nh, no homolog; ph, positional homolog in the respective virus.
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the latent nuclear antigen of KSHV, LANA, repetitive se-
quence; 76.1%) are more variable.
Viral glycoproteins
The analysis of the HVS C488 ORFs with the programs
PSORT II and SignalP (Nakai and Horton, 1999; Nielsen et
al., 1997) revealed that 11 predicted proteins contain puta-
tive eukaryotic signal sequences at their N-terminus (Table
1). Further comparison with conserved amino acid motifs
from the PROSITE database (Hofmann et al., 1999) showed
that most of these ORFs also contained N-glycosylation
sites (N-X-T/S). ORF8, ORF22, ORF39, and ORF47 are the
HVS sequence homologs to the glycoproteins gB, gH, gM,
and gL of herpes simplex virus (HSV) and cytomegalovirus
(CMV), respectively. A small glycoprotein encoded by
ORF53 (90 aa) has homologs in HVS A11, KSHV, RRV,
MHV-68, AHV-1, and EBV and may correspond to gN of
- and -herpesviruses. The glycoproteins ORF4/CCPH
and ORF15/vCD59 are functional viral homologs to com-
plement regulatory proteins (Albrecht and Fleckenstein,
1992; Albrecht et al., 1992b; Fodor et al., 1995; Rother et
al., 1994), and ORF13 and ORF14 are homologs to the
glycoprotein IL-17 and to murine superantigens (Sag)
Fig. 2. (A) HVS genome organization. Genes with more than 10% aa divergence between the HVS strains A11 and C488 are marked in black. (B) Amino
acid conservation of the individual HVS reading frames between the strains A11 and C488. Each bar represents one viral open reading frame. Proteins with
significant divergence are indicated by name.
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(Duboise et al., 1998a; Knappe et al., 1997, 1998a,b; Nich-
olas et al., 1990; Yao et al., 1995).
The putative type I transmembrane glycoprotein ORF51
has weakly conserved, but positionally equivalent, Ser- and
Thr-rich homologs in many -herpesviruses. The EBV ho-
molog gp350/220 mediates attachment to the EBV receptor
on B cells (CD21) (Fingeroth et al., 1984). The MHV-68
homolog M7 encodes gp150 that is expressed in infected
cells and present in virions. Antisera to gp150 neutralize
virion-associated infectivity, and the mononucleosis-like
syndrome is prevented by immunization with recombinant
gp150 vaccinia vectors (Stewart et al., 1996, 1999). AHV-1
A8 and BHV-4 BORF D1 encode similar glycoproteins
(Ensser et al., 1997; Lomonte et al., 1995; Zimmermann et
al., 2001). The major immunogenic glycoprotein of KSHV
is encoded by K8.1 from a spliced transcript and is included
in the viral envelope (Li et al., 1999; Raab et al., 1998). The
RRVs also contain the equivalent R8.1 (Alexander et al.,
2000; Searles et al., 1999). Interestingly, the glycoprotein
R8.1 was highly conserved between the RRVs, as was K8.1
between different KSHV isolates, whereas HVS isolates of
different subgroups show the most pronounced glycoprotein
sequence divergence in ORF51 (61%). The putative mem-
brane glycoprotein encoded by HVS ORF51 is a candidate
for the interaction with a specific host cell receptor. The
positional homologs in the rhadinoviruses BHV-4, RRV,
and KSHV are encoded by spliced transcripts; RT-PCR
experiments indicated that, similarly to the situation in
MHV-68, the HVS ORF51 is derived from an unspliced
message (data not shown).
Among the HVS genes with pronounced interstrain vari-
ation were several glycoproteins, namely ORF4/CCPH,
ORF22/gH, ORF28, ORF47/gL, ORF51, and ORF53/gN. A
similar situation was observed for the genomes of the two
sequenced rhesus rhadinovirus isolates where ORF4/CCPH,
ORF22/gH, and ORF47/gL also showed a high degree of
sequence variation (Alexander et al., 2000; Auerbach et al.,
2000; Searles et al., 1999). The selective pressure exerted by
the host immune system induces diversity of the immuno-
genic glycoproteins. The significant sequence variability of
these immunogenic proteins may relate to the fact that
squirrel monkeys can be infected with different HVS iso-
lates at the same time (Desrosiers and Falk, 1982; Ficken-
scher et al., 1997; Medveczky et al., 1984, 1989), which was
also observed in this study (Table 2, Fig. 5B).
Conservation of cellular homologs
A series of HVS genes was previously recognized as
pirated homologs of cellular genes. These cell-homologous
genes are localized to the left and right ends of the L-DNA
genome. At the left terminus, such genes flank a conserved
block of typical herpesvirus genes (ORF6 to ORF11), end-
ing with ORF16/vBcl-2. The respective region at the right
L-DNA end starts with ORF70/thymidylate synthase. Thus,
the terminal regions of the -herpesvirus genomes are inte-
gration sites for cellular genes, probably facilitated by the
viral replication that was described to originate in these
genome regions (Kung and Medveczky, 1996; Schofield,
1994). Most of the cell-homologous proteins are highly
conserved between the HVS strains A11 and C488, among
them ORF13/vIL-17, ORF14/vSag, ORF16/vBc12, ORF71/
vFLIP, ORF72/vCyclin, ORF74/vIL-8 receptor, and en-
zymes of nucleotide metabolism, namely ORF21/thymidine
kinase, ORF54/dUTPase, ORF70/thymidylate synthase, and
ORF3 and ORF75, the two homologs to N-formylglycine-
amide ribotide amidotransferase (vFGARAT). ORF2
(DHFR) is localized in the highly divergent transformation-
associated genomic L-DNA region and is only 80.5% con-
served. Recently, ORF12 was described to show a limited
Table 2
In vitro transformation of T cells from human and Saguinus oedipus with new HVS isolates.
Saimiri
sciureus
no.
From
colony
no.
HVS
subgroup
T cell transformation
Human Saguinus oedipus
CB-84 CB-94 B240 R178
6045 1 B c  Delayed Delayed
6051 1 A  (C)b    
8907 1 C Delayed Delayed  
5746 2 C  Delayed  
5747 2 A  (C)    
5753 2 C    
5947 3 C Delayed   
5945 3 C    
5952 3 C Delayed   
6661 1  2a (A)  C    
6355 2  3 A    
C488 — C    
a Parents were from different colonies.
b In case of double infections, the less dominant subgroup is given in parentheses.
c , transformation was not achieved; , successful transformation experiment.
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similarity to the K3 and K5 proteins of KSHV which down-
regulate MHC class I surface expression and block the
susceptibility to natural killer cells (Coscoy and Ganem,
2000; Ishido et al., 2000a,b). In addition, homologies to
HVS ORF12 are found in BHV-4, in poxviruses (r153R of
rabbit fibroma virus and VC07 of swine poxvirus), and in
the human genome (NP_057580, NP_060393). ORF12 of
HVS C488 was dispensable for replication and T cell trans-
formation (Knappe et al., 1998a). Whereas the complement
regulator ORF15/vCD59 is almost identical, the secreted or
membrane-bound ORF4/CCPH shows the highest variabil-
ity in the group of cell-homologous genes between the
strains A11 and C488 (38.6 or 42.7%, respectively). Previ-
ously, we showed that the genes encoding vIL-17 and vSag,
as well as the vFLIP and the vCyclin genes are dispensable
for in vitro transformation and pathogenicity in cottontop
tamarins (Ensser et al., 2001; Glykofrydes et al., 2000;
Knappe et al., 1997, 1998a,b). Altogether, the high degree
of conservation of the cell-homologous viral proteins and
the results with the respective deletion viruses indicate that
they are not involved in the T cell transformation process or
at least cannot explain a differential transforming phenotype
of HVS strains. However, the high conservation level sug-
gests an important role in the viral replication and persis-
tence in the natural host species where HVS is an apatho-
genic passenger circumventing the squirrel monkey’s
immune defense.
The positional homolog to the latent nuclear antigen of
KSHV
In KSHV, ORF73 is the major latent nuclear antigen
which was suggested to be involved in the plasmid replica-
tion of persisting virus genomes (Ballestas et al., 1999).
However, orf73 expression in HVS-transformed human T
cells is not detectable by Northern blot analysis (Ficken-
scher et al., 1996; Knappe et al., 1997), although orf71 and
orf72, which are located on the same transcript, are detect-
able by more sensitive RT-PCR (Glykofrydes et al., 2000).
The HVS C488 ORF73 protein (501 aa) is smaller than
KSHV ORF73/LANA (1089 aa), but considerably larger
than the HVS A11 counterpart (407 aa). HVS C488 ORF73
is able to maintain the latent state of HVS in permissive
cells by suppressing ORF50 R-transactivator expression
(Scha¨fer et al., 2003). ORF73 is characterized by a highly
repetitive and highly charged central region containing Glu-
Arg, Glu-Gly, and Glu-Ala motifs. The N-terminus contains
nuclear localization signals similar to A11 ORF73 (Hall et
al., 2000), and the C-terminal region resembles the DNA-
binding domain of EBNA-1 of EBV (Bochkarev et al.,
1995). Whereas the ORF73/LANA proteins of two RRV
isolates are highly conserved, the ORF73 sequences of the
HVS A and C strains diverge considerably (23.9%; Table
1). The variability of ORF73 between different rhadinovirus
species is high; however, the N- and/or C-terminal se-
quences are better conserved. The Pro-rich sequences in the
N-terminal ORF73 regions of equine herpesvirus 2 (EHV-
2), MHV-68, RRV, and KSHV are missing in HVS and
HVA. In contrast, the extensive Gly-Glu/Asp and Gly-Arg
domains of KSHV, HVS, HVA, or EHV-2 are lacking in
RRV and MHV-68.
Viral regulatory genes
The HVS genome contains only a few genes which may
have regulatory functions for virus replication. One imme-
diate-early gene, orf14, is a superantigen homolog, but was
ruled out to be involved in replication (Duboise et al.,
1998a; Knappe et al., 1997, 1998b). The immediate-early
regulatory protein ORF57 of C488 is highly conserved, and
ORF57 of strain A11 was shown to repress the expression
of spliced viral transcripts at a posttranscriptional level.
ORF57 is a nucleocytoplasmatic shuttle protein which co-
localizes with the splicing factor SC-35, binds to importins,
and regulates both orf50a and its own transcription at a
posttranscriptional level (Cooper et al., 1999; Goodwin and
Whitehouse, 2001; Goodwin et al., 1999, 2000; Whitehouse
et al., 1998b). An observed N-terminal sequences diver-
gence of the HVS ORF57 proteins was resolved by remov-
ing an erroneous nucleotide (position 78,288) in the A11
genome (Albrecht et al., 1992a). Although there is consid-
erable sequence variability between orf57 of HVS and
KSHV, the splicing pattern is conserved (Bello et al., 1999;
Kirshner et al., 2000).
orf50 encodes a regulatory protein homologous to
Fig. 3. Restriction fragment length polymorphism of HVS subgroup C
isolates. Virion DNA of new virus isolates (Table 2) and strain C488 was
cleaved with either XbaI/PstI or HindIII/PstI and subsequently analyzed by
Southern blot hybridization with an stpC-specific radioactive probe. In
accordance to the PCR-based subgroup assignment, weak signals were also
observed with the isolates 5747 and 6051, which simultaneously contained
a dominant subgroup A strain.
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BRLF-1 or the R transactivator (Rta) of EBV (Chang et al.,
1998; Liu et al., 1996). The HVS orf50/Rta gene is ex-
pressed in two forms. The larger ORF50A protein is trans-
lated from a spliced transcript, and the smaller C-terminal
ORF50B is derived from shorter transcripts initiating down-
stream of the orf50a splice acceptor site. A11 ORF50A
transactivated transcription from early virus gene promoters
such as the major DNA binding protein (orf6) promoter,
Fig. 4. Alignment of the StpC (A) and Tip (B) protein sequences of new HVS isolates and laboratory strains (Table 2 and Fickenscher et al., 1997). Conserved
tyrosine residues are marked with triangles. CSKH, C-terminal Src-kinase homology domain; SH3B, Src-homology 3 binding domain.
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whereas A11 ORF50B had a strongly reduced transactiva-
tion function (Whitehouse et al., 1997a, 1997b; 1998a).
However, in contrast to strain A11, C488 ORF50B showed
full transactivation capability (Thurau et al., 2000). Only
ORF50A, and not ORF50B, of both HVS strains A11 and
C488 reactivated lytic virus replication in persistently in-
fected A549 human lung carcinoma cells (Goodwin et al.,
2001). In the C-terminal portion, all ORF50 forms carry a
bipartite nuclear localization signal which includes a typical
high-affinity DNA-binding AT hook type I motif as con-
Fig. 5. Alignment of variable protein sequences of new HVS isolates and laboratory strains (Table 2). (A) ORF50b alignment. NLS, bipartite nuclear
localization signal, predicted with PSORT II (Nakai and Horton, 1999); AT-hook, putative high-affinity DNA-binding AT hook type I motif of minor groove
DNA binding proteins such as high mobility group I-C protein (Aravind and Landsman, 1998). TBP, the interaction site with TATA binding protein (TBP)
contains three essential amino acids (*) which are conservatively exchanged (Hall et al., 1999). (B) ORF51 alignment. Signal peptide and transmembrane
domains, predicted with SignalP and TMHMM (Nielsen et al., 1997) *, N-glycosylation sites (top for C488, bottom for A11).
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tained in minor groove DNA binding proteins such as the
high-mobility group I-C protein (Aravind and Landsman,
1998). The C-terminus of the ORF50 proteins shows con-
servative exchanges within the activation domain which
interacts with TATA binding protein (Fig. 5A) (Hall et al.,
1999). In contrast to the highly conserved ORF57, HVS
C488 ORF50 is one of the most variable proteins. KSHV
ORF50 selectively upregulates delayed-early viral genes,
disrupts latency, and induces the lytic gene expression cas-
cade in latently infected B cells (Lukac et al., 1998, 1999).
In cells dually infected with EBV and KSHV, each Rta
activated only the autologous lytic cycle genes (Sun et al.,
1998). KSHV ORF50 binds to the cellular CREB protein
and histone deacetylase, which modulates ORF50-activated
viral transcription (Gwack et al., 2001). Similarly, MHV-68
ORF50 transactivates the orf57 promoter, induces the ex-
pression of early and late genes, the lytic replication of viral
DNA, and the production of infectious viral particles (Liu et
al., 2000; Wu et al., 2000).
Sequence divergence of 11 new HVS isolates
The results from the genome comparison of two virus
strains of the same species can be strongly biased if the
viruses accumulate mutations during long-term passage in
cell culture. This problem is largely excluded for the strain
C488 which was passaged only for a few times from a
sample frozen early after isolation (Fickenscher et al.,
1997). However, for strain A11 the passage history is un-
clear. To exclude artifacts and to obtain more knowledge on
the variability of HVS strains, we isolated and analyzed 11
new HVS strains from three different squirrel monkey (S.
sciureus) colonies of the German Primate Center in Go¨ttin-
gen (Greve et al., 2001). Using stp allele-specific DNA PCR
(Ho¨r et al., 2001), these isolates were assigned to the three
HVS subgroups (Table 2) (Medveczky et al., 1984, 1989).
In three cases, a coinfection of the same animal with viruses
from different subgroups was detectable, similar to other
cases in the literature (Desrosiers and Falk, 1982; Ficken-
Fig. 5 (continued)
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scher et al., 1997; Medveczky et al., 1984, 1989). The nine
subgroup C isolates showed a restriction length polymor-
phism in the left-terminal L-DNA region coding for the
StpC and Tip oncoproteins (Fig. 3). The transformation-
associated regions of the new subgroup C viruses were
sequenced and compared with the previously known alleles
(Biesinger et al., 1990; Fickenscher et al., 1997; Geck et al.,
1990). Whereas only minor variations were observed in the
StpC proteins (Fig. 4A), the 13 available Tip protein se-
quences could be assigned to three families (Fig. 4B) with
the prototype viruses C488, C484(M), and C139, as sug-
gested in a previous study (Fickenscher et al., 1997).
Since we had already observed a pronounced structural
and functional variation of the orf50 genes between strains
A11 and C488 (Thurau et al., 2000), the entire orf50 regions
were amplified and the sequences from the 11 new isolates
(three subgroup A, one subgroup B, and seven subgroup C
sequences) were compared with the A11 and C488 alleles.
The most pronounced diversity was observed for orf50b and
orf51 (Fig. 5). The whole region occurs in two alleles: one
allele is specific for subgroup A and B; the other allele is
specific for subgroup C strains. Laboratory strain-specific
artifacts can be excluded, as the whole region occurs in two
alleles within the prototype A11, C488, and the new iso-
lates. The capability of transforming human T cells in cul-
ture strictly correlated with the assignment to subgroup C
(Table 2). Thus, different alleles of orf50 and orf51 seem to
strictly segregate with the transforming genes of the respec-
tive subgroup. A contribution of this segregation of orf50
and orf51 to the phenotypic differences between the sub-
groups remains to be investigated. Subgroup C viruses
might have a stronger affinity to their receptor on human T
cells due to their specific ORF51 protein. Thus, besides the
transformation-associated region, the variability of HVS
strains localizes mainly to proteins with repetitive motifs
(ORF48, ORF73), to the capsid protein ORF65, to several
glycoproteins (ORF4, ORF22, ORF28, ORF47, ORF51,
ORF53), and to the transactivator ORF50/Rta. This vari-
ability evolved in the natural host, the squirrel monkey, and
might afflict primary and persistent infection. However,
since subgroup C strains of HVS have the unique capability
of transforming human T cells in culture, the functional
contribution of these additional genes to the transforming
phenotype remains a relevant question.
Materials and methods
Cell lines and virus culture
Owl monkey kidney (OMK) cells (ATCC CRL1556)
(Daniel et al., 1976) were propagated in Dulbecco’s mini-
mal essential medium with 10% fetal calf serum, 100 g/ml
gentamycin, and 350 g/ml L-glutamine. HVS strain C488
(Biesinger et al., 1990; Desrosiers and Falk, 1982) was
propagated for a few passages by infection of fresh OMK
cells with supernatant from infected cells showing severe
cytopathic changes. For virion preparation, the supernatant
was precleared from cellular debris by centrifugation at
2000 g. Virions were then sedimented by ultracentrifugation
and purified on sucrose density gradients. After lysis of the
virions, the virus DNA was prepared by equilibrium CsCl
density gradient ultracentrifugation (Fickenscher and Fleck-
enstein, 2002).
Pulse-field agarose gel electrophoresis
Clamped homogenous electric field electrophoresis was
performed with 1% fast-lane agarose gels (FMC, Biozym,
Hessisch-Oldendorf, Germany) in 0.5 TBE buffer with a
CHEF DR-III System (Bio-Rad, Munich, Germany) set to 6
V/cm at an angle of 120° for 14 h, with switch time incre-
menting linearly from 2 to 20 s. Approximately 0.5 g of
gradient purified virion DNA was loaded per lane along
with the midrange marker I (New England Biolabs, Frank-
furt, Germany).
Isolation of HVS from squirrel monkeys
Blood samples (1–2 ml) were obtained from 11 squirrel
monkeys of three different colonies at the German Primate
Center, Go¨ttingen. The peripheral blood mononuclear cells
(PBMC) were prepared by direct centrifugation of EDTA
blood. The erythrocytes were lysed by treatment with ACK
buffer (0.15 M NH4Cl, 10 mM KHCO3, 0.1 mM Na2EDTA,
pH 7.3) for 5 min followed by extensive washing in phos-
phate-buffered saline. Freshly isolated PBMC (approxi-
mately 106 cells) from each animal were cocultivated with
permissive OMK cells to isolate the virus. After a typical
cytopathic effect had led to cell lysis, the virus isolates were
assigned to the subgroups by DNA PCR (Ho¨r et al., 2001)
for the respective transformation-associated genes stpA,
stpB, and stpC. The 11 virus isolates were tested for their
capability of transforming human (two cord blood donors)
and cottontop tamarin T cells (donors B240 and R178)
(Greve et al., 2001; Knappe et al., 1998a, 1998b).
Virions were concentrated by centrifugation from 1 ml of
virus supernatant. The virion DNA was released in sodium
dodecyl sulfate buffer in the presence of proteinase K fol-
lowed by phenol/chloroform extraction and ethanol precip-
itation. Virion DNA was cut with either XbaI/PstI or
HindIII/PstI and analyzed by Southern blot hybridization
with an stpC-specific DNA probe. The terminal transforma-
tion-associated and the variable orf50 regions of the new
isolates were amplified by PCR with Taq polymerase from
virion DNA and sequenced from at least two independent
clones. In the rare case of divergence between these two
sequenced clones, additional independent clones and PCR
products were sequenced. The sequence readings were elec-
tronically processed as described below. The stpC/tip region
sequence contigs comprised 1540 nt in average with a
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redundance of 7.06 and the orf50 region contigs comprised
3866 nt in average with a redundance of 8.38.
Cloning of the C488 genome
Purified genomic virion DNA was digested with the
restriction enzymes HindIII or XbaI and cloned as small
fragments into the plasmid vector pBluescript KS
(Knappe et al., 1997). For subcloning of larger fragments
into cosmid vectors, 2 g of viral DNA was partially di-
gested with the restriction enzyme Sau3AI, resulting in an
average fragment size of 30 to 60 kb as judged by analytical
pulse-field gel electrophoresis (Ensser et al., 1999). These
fragments were ligated to 1 g of dephosphorylated
BamHI-cut cosmid vector pWE15 (Stratagene, Amsterdam,
The Netherlands) and packaged into lambda phage particles
(Gigapack II Gold, Stratagene). The packaged cosmids were
transduced into Escherichia coli JM109 cells grown in LB
medium with 0.2% maltose and 10 mM MgSO4. Colonies
from LB agar plates with 50 g/ml ampicillin were subse-
quently screened by small-scale alkaline lysis, restriction
enzyme mapping, pulse-field gel electrophoresis, and se-
quencing of the cosmid insert ends. Large-scale preparation
of cosmid DNA was done by alkaline lysis and anion
exchange chromatography or CsCl-equilibrium gradient ul-
tracentrifugation. Insert DNA from right-terminal L-DNA
region (cosmids Dc5 and cos40) was sheared by sonification
to fragments of 1–3 kb; the DNA ends were blunted with
Klenow and T4-DNA polymerase and cloned into the vector
pCRScript (Stratagene). Plasmid and cosmid DNA from E.
coli DH5 or DH10B was sequenced using either ABI
373A or 377 PRISM analyzers and the Taq dye deoxyter-
minator chemistry (Applied Biosystems, Weiterstadt, Ger-
many). Oligonucleotides were synthesized by Eurogentec
(Seraing, Belgium) or Sigma-ARK (Darmstadt, Germany).
The sequence readings were assembled with the program
XBAP (Dear and Staden, 1991) on a Sparcstation10 (SUN
Microsystems, Mountain View, CA). Oligonucleotides
were selected using the program OSP (Hillier and Green,
1991) implemented in XBAP.
Nucleotide and protein sequence analysis
The GCG package (version 7, Devereux et al., 1984)
with the programs FASTA (Pearson and Lipman, 1988) and
BLAST (Altschul et al., 1990; Gish and States, 1993) were
used for analysis of nucleotide and amino acid sequences
and for comparison with the GenBank and Swissprot data-
bases (versions 113.0 and 37.0, respectively). Potential cod-
ing regions were identified with the program GENEMARK
(Borodovsky et al., 1994) using matrices for eukaryotic
(human) and -herpesviral DNA (kindly compiled by Wil-
liam Hayes, Georgia Institute of Technology, Atlanta, GA).
Putative signal sequences and protein structure were ana-
lyzed by the neuronal network-based SignalP trained on
eukaryotic sequences (Nielsen et al., 1997), by PSORT II
(Nakai and Horton, 1999), and by comparison to the
PROSITE database (Hofmann et al., 1999). Protein and
nucleotide sequences were aligned with the programs Clust-
alW and BioEdit (T. Hall, North Carolina State University,
Raleigh, NC). The complete L-DNA sequence of HVS
C488 is deposited under the EMBL Accession No.
AJ410493; the terminal H-DNA repeat sequence is depos-
ited under AJ410494. The individual sequences of the stpC/
tip regions and orf50 regions of the new HVS isolates were
assigned to the EMBL Accession No. AJ410475 to
AJ410481 and AJ410482 to AJ410492, respectively.
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